Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Operating Leases (2022 - 2025)

Envoy Medical's Operating Leases history spans 4 years, with the latest figure at $946000.0 for Q3 2025.

  • For Q3 2025, Operating Leases fell 7.98% year-over-year to $946000.0; the TTM value through Sep 2025 reached $946000.0, down 7.98%, while the annual FY2024 figure was $802000.0, 98.51% up from the prior year.
  • Operating Leases for Q3 2025 was $946000.0 at Envoy Medical, up from $900000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.1 million in Q2 2024 and bottomed at $378000.0 in Q1 2024.
  • The 4-year median for Operating Leases is $790000.0 (2024), against an average of $751100.0.
  • The largest annual shift saw Operating Leases decreased 28.5% in 2023 before it skyrocketed 105.82% in 2025.
  • A 4-year view of Operating Leases shows it stood at $565000.0 in 2022, then fell by 28.5% to $404000.0 in 2023, then skyrocketed by 98.51% to $802000.0 in 2024, then increased by 17.96% to $946000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Operating Leases are $946000.0 (Q3 2025), $900000.0 (Q2 2025), and $778000.0 (Q1 2025).